Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 14, Issue 13, pp. 4192-4199
PubMed
Published By
Print ISSN
Online ISSN
History
- Accepted March 13, 2008
- Received December 29, 2007
- Revision received February 29, 2008
- Published first July 1, 2008.
Copyright & Usage
American Association for Cancer Research
Author Information
- Pierpaolo Correale1,
- Pierosandro Tagliaferri5,
- Antonella Fioravanti2,
- Maria Teresa Del Vecchio3,
- Cinzia Remondo1,
- Francesco Montagnani1,
- Maria Saveria Rotundo5,
- Chiara Ginanneschi3,
- Ignazio Martellucci1,
- Edoardo Francini1,
- Maria Grazia Cusi4,
- Pierfrancesco Tassone5 and
- Guido Francini1
- Authors' Affiliations:1Section of Medical Oncology, Department “Giorgio Segre” of Pharmacology, 2Rheumatology Unit, Department of Clinical Medicine and Immunological Sciences, 3Pathology Section, Department of Human Pathology and Oncology, and 4Section of Microbiology, Department of Molecular Biology, Siena University School of Medicine, Siena, Italy; and 5Medical Oncology Unit, “Campus Salvatore Venuta,” “Magna Graecia University, School of Medicine,” Catanzaro, Italy
- Requests for reprints:
Guido Francini, Section of Medical Oncology, Division of Medical Oncology, Siena University School of Medicine, Viale Bracci 11, 53100 Siena, Italy. Phone: 39-0577-586369; Fax: 39-0577-586133; E-mail: correale{at}unisi.it.
July 2008
Volume 14, Issue 13
Volume 14, Issue 13
Immunity Feedback and Clinical Outcome in Colon Cancer Patients Undergoing Chemoimmunotherapy with Gemcitabine + FOLFOX followed by Subcutaneous Granulocyte Macrophage Colony-Stimulating Factor and Aldesleukin (GOLFIG-1 Trial)
Jump to section
Advertisement